Thursday, April 26, 2018
 
 
New Migraine Registry Offers Hope for Patients
EVANSTON, Ill., April 26, 2018 /PRNewswire/ -- Patient registries can significantly advance the understanding and treatment of a particular disease. According to the American Migraine Foundation (AMF), migraine is estimated to affect more than 37 million people in the U.S., however, a large, comprehensive, multicenter patient.....
 
Winthrop Urology Announces Dr. Jeffrey Schiff's Designation as UroLift® Center of Excellence
GARDEN CITY, N.Y., April 26, 2018 /PRNewswire-PRWeb/ -- Winthrop Urology today announced that Dr. Jeffrey Schiff has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Schiff has achieved a high level of training and experience with the UroLift System and dem.....
 
Alkermes Plc Reports First Quarter 2018 Financial Results
DUBLIN, April 26, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2018.
 
Neurocrine Biosciences Presents New Data Analyses at AAN Annual Meeting Demonstrating INGREZZA® Improved Tardive Dyskinesia Symptoms Across Body Regions
SAN DIEGO, April 25, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD), improved TD symptoms regardless of body region. These .....
 
Asm. Autumn Burke and Marie Waldron's Breast Cancer Genetic Testing Bill Clears Committee
SACRAMENTO, Calif., April 25, 2018 /PRNewswire/ -- Assemblywomen Autumn Burke (D- Inglewood) and Marie Waldron's (R- Escondido)  legislation ensuring that women who are high-risk for breast and ovar.....
 
Centers for Psychiatric Excellence (COPE) Complete Integration of Online Assessment and Tracking Software with CLINICOM™ to Help Improve Long-Term Patient Outcomes
DOTHAN, Ala., April 25, 2018 /PRNewswire/ -- Forty percent of all psychiatric disorders are treatment-resistant.  Of these, major depression, one of the most common psychiatric disorders in the United States, is overrepresented.  In 2016, an estimated 16......
 
Bayside Urologist Dr. Riccardo Ricciardi Designated a UroLift® Center of Excellence
BAYSIDE, N.Y., April 25, 2018 /PRNewswire-PRWeb/ -- Advanced Urology Centers of New York today announced that Dr. Riccardo Ricciardi has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Ricciardi has achieved a high level of.....
 
RESOLVE Partners with Corporate America to Help Build Families
MCLEAN, Va., April 25, 2018 /PRNewswire-PRWeb/ -- In honor of National Infertility Awareness Week, April 22-28, 2018, RESOLVE: The National Infertility Association will ring the Nasdaq Stock Market Closing Bell on
 



Feinstein Institute researcher nominated to Association of American Physicians
MANHASSET, N.Y., April 24, 2018 /PRNewswire-USNewswire/ -- Northwell Health's Feinstein Institute for Medical Research Professor John, M K.....
 
Children's Hospital of Philadelphia Announces Expansion of Multi-Partner Medical Legal Partnership
PHILADELPHIA, April 24, 2018 /PRNewswire-USNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced the expansion of its Multi-Partner Medical Legal Partnership (MLP), a collaboration between the Hospital and the University of Pennsylvania Law School.....
 
Brain Food: How What You Eat Can Help You When Studying
GAITHERSBURG, Md., April 24, 2018 /PRNewswire/ -- If you are what you eat, then what should you eat (or not eat) to help you retain information when studying for final exams? Sodexo national dietitian Beth Winthrop, who helps the company's college and university clients create healthy, well-bal.....
 
AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies
INDIANAPOLIS, April 24, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today results from a post-hoc subgroup analysis which demonstrated efficacy of galcanezumab in patients with episodic and chronic migraine who previously failed to respond to two or more preventive therapies. Detailed results from a new s.....
 


 
 
 
 
 
 
 
 
Seniors

Drugs
  • Centene Corporation Reports 2018 First Quarter Results And Adjusts 2018 Guidance
  • "The Future of Getting Old" - With Old Age, New Possibilities
  • Analysis of Global "Medical Device & Accessories Market" Scope | Set for Rapid Growth 6.53% of CAGR during 2018 to 2023 | Topmost Players, Top Regional Trend & Segments | MarketResearchFuture.com
  • Pain Management Device Market Factor Analysis 2018 - Technological and Product Development to Drive the Global Industry by 2023
  • Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases

    Cancer
  • World “Americas Interventional Radiology” Market Competitive Landscape with Phenomenal Growth CAGR 5.12% MRFR Unleashing Market Forecast by 2023
  • Quality Cancer Care: Not Just a Matter of Anti-cancer Medicines
  • Global Biosensors Market 2018-2027: Rising Geriatric Population and Rapid Incorporation of Biosensing Technologies in Non-Medical Applications
  • "21+ Reasons Why" Showcases Support for Tobacco 21
  • Samsung BioLogics becomes the first in the South Korean pharma industry to achieve ISO 22301 Certificate
  •  
     
     
     
     
     





    About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines